Transgenic mouse lines that are immunologically tolerant and nontolerant to herpes simplex virus glycoprotein D
- PMID: 1717714
- PMCID: PMC250292
- DOI: 10.1128/JVI.65.11.6124-6128.1991
Transgenic mouse lines that are immunologically tolerant and nontolerant to herpes simplex virus glycoprotein D
Abstract
A construct containing the gene for glycoprotein D of herpes simplex virus (HSV-gD), under the control of the simian virus 40 early promoter, was microinjected into single-cell embryos, and four transgenic mouse lines were established. Three were homozygous (lines 75, 111, and 113) and one was hemizygous (line 108) for the HSV-gD gene. Examination of sera revealed that only one of the lines (line 75) spontaneously produced antibody to HSV-gD. Immunization of the other three lines with vaccinia virus-HSV-gD showed that one of them (line 113) responded by making antibody to HSV-gD, whereas the other two (lines 108 and 111) appeared to be immunologically tolerant. Evidence that tolerance was not absolute was obtained by immunization with infectious HSV, which resulted in an antibody response to HSV-gD in some of the animals from line 111. Examination of organs for HSV-gD mRNA revealed transcripts in the tolerant line (line 108) and in the partially tolerant line (line 111), but not in the nontolerant line (line 113), suggesting that the development of immunological tolerance requires active expression of the HSV-gD gene.
Similar articles
-
Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.J Virol. 2017 Sep 12;91(19):e00411-17. doi: 10.1128/JVI.00411-17. Print 2017 Oct 1. J Virol. 2017. PMID: 28701403 Free PMC article.
-
Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.J Gen Virol. 1991 Feb;72 ( Pt 2):369-75. doi: 10.1099/0022-1317-72-2-369. J Gen Virol. 1991. PMID: 1704412
-
Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D.Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S924-34. doi: 10.1093/clind/13.supplement_11.s924. Rev Infect Dis. 1991. PMID: 1664130 Review.
-
Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.J Infect Dis. 1989 Apr;159(4):625-34. doi: 10.1093/infdis/159.4.625. J Infect Dis. 1989. PMID: 2538519
-
Live vaccinia virus recombinants expressing herpes simplex virus genes.Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S898-903. doi: 10.1093/clind/13.supplement_11.s898. Rev Infect Dis. 1991. PMID: 1664124 Review.
Cited by
-
Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).Immunology. 1997 Feb;90(2):219-28. doi: 10.1046/j.1365-2567.1997.00157.x. Immunology. 1997. PMID: 9135550 Free PMC article.
-
Induction of tolerance to a recombinant human enzyme, acid alpha-glucosidase, in enzyme deficient knockout mice.Transgenic Res. 2003 Apr;12(2):171-8. doi: 10.1023/a:1022998010833. Transgenic Res. 2003. PMID: 12739885
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical